Efficacy and Safety of Kinesiology Tape Wrapping for Paronychia Induced by Epidermal Growth Factor Receptor Inhibitors - Trial NCT06411093
Access comprehensive clinical trial information for NCT06411093 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Completed. The study focuses on Paronychia,Epidermal Growth Factor Receptor Inhibitor. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Kinesiology tape wrapping
Interventional
combination product
Sponsor & Location
Chang Gung Memorial Hospital
Timeline & Enrollment
N/A
Mar 02, 2023
Dec 31, 2023
Primary Outcome
Change in the severity of pain by Numerical Rating Scale,Change in the severity of paronychia by the scoring system for paronychia related to oncologic treatments (SPOT)
Summary
Epidermal growth factor receptor inhibitors(EGFRIs) have been applied in several common
 malignancies including advanced non-small cell lung cancer. Paronychia is one of the most
 common cutaneous side effects, characterized by inflamed granulation tissue around the nails
 leading to pain and reduced quality of life. Despite available conventional therapies such as
 topical beta-blockers or chemical cauterization, some patients still do not respond well. Our
 previous pilot study suggested that adding Kinesiology tape wrapping to the conventional
 treatment may effectively improve pain and granulomas in patients with treatment-resistant
 EGFRI-related paronychia, with good safety. This study aims to evaluate the clinical efficacy
 and safety of using Kinesiology tape wrapping as an adjunct to conventional therapy for
 patients with EGFRI-related paronychia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411093
Non-Device Trial